Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.
Shulman DS, Whittle SB, Surdez D, Bailey KM, de Álava E, Yustein JT, Shlien A, Hayashi M, Bishop AJR, Crompton BD, DuBois SG, Shukla N, Leavey PJ, Lessnick SL, Kovar H, Delattre O, Grünewald TGP, Antonescu CR, Roberts RD, Toretsky JA, Tirode F, Gorlick R, Janeway KA, Reed D, Lawlor ER, Grohar PJ. Shulman DS, et al. Among authors: lawlor er. NPJ Precis Oncol. 2022 Sep 17;6(1):65. doi: 10.1038/s41698-022-00307-2. NPJ Precis Oncol. 2022. PMID: 36115869 Free PMC article. Review.
EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma.
de Alava E, Kawai A, Healey JH, Fligman I, Meyers PA, Huvos AG, Gerald WL, Jhanwar SC, Argani P, Antonescu CR, Pardo-Mindan FJ, Ginsberg J, Womer R, Lawlor ER, Wunder J, Andrulis I, Sorensen PH, Barr FG, Ladanyi M. de Alava E, et al. Among authors: lawlor er. J Clin Oncol. 1998 Apr;16(4):1248-55. doi: 10.1200/JCO.1998.16.4.1248. J Clin Oncol. 1998. PMID: 9552022
Current treatment protocols have eliminated the prognostic advantage of type 1 fusions in Ewing sarcoma: a report from the Children's Oncology Group.
van Doorninck JA, Ji L, Schaub B, Shimada H, Wing MR, Krailo MD, Lessnick SL, Marina N, Triche TJ, Sposto R, Womer RB, Lawlor ER. van Doorninck JA, et al. Among authors: lawlor er. J Clin Oncol. 2010 Apr 20;28(12):1989-94. doi: 10.1200/JCO.2009.24.5845. Epub 2010 Mar 22. J Clin Oncol. 2010. PMID: 20308669 Free PMC article.
CD133 expression in chemo-resistant Ewing sarcoma cells.
Jiang X, Gwye Y, Russell D, Cao C, Douglas D, Hung L, Kovar H, Triche TJ, Lawlor ER. Jiang X, et al. Among authors: lawlor er. BMC Cancer. 2010 Mar 26;10:116. doi: 10.1186/1471-2407-10-116. BMC Cancer. 2010. PMID: 20346143 Free PMC article.
The first European interdisciplinary ewing sarcoma research summit.
Kovar H, Alonso J, Aman P, Aryee DN, Ban J, Burchill SA, Burdach S, De Alava E, Delattre O, Dirksen U, Fourtouna A, Fulda S, Helman LJ, Herrero-Martin D, Hogendoorn PC, Kontny U, Lawlor ER, Lessnick SL, Llombart-Bosch A, Metzler M, Moriggl R, Niedan S, Potratz J, Redini F, Richter GH, Riedmann LT, Rossig C, Schäfer BW, Schwentner R, Scotlandi K, Sorensen PH, Staege MS, Tirode F, Toretsky J, Ventura S, Eggert A, Ladenstein R. Kovar H, et al. Among authors: lawlor er. Front Oncol. 2012 May 29;2:54. doi: 10.3389/fonc.2012.00054. eCollection 2012. Front Oncol. 2012. PMID: 22662320 Free PMC article.
A Decade in Banking Ewing Sarcoma: A Report from the Children's Oncology Group.
Borinstein SC, Beeler N, Block JJ, Gorlick R, Grohar P, Jedlicka P, Krailo M, Morris C, Phillips S, Siegal GP, Lawlor ER, Lessnick SL; COG Ewing Sarcoma Biology Committee. Borinstein SC, et al. Among authors: lawlor er. Front Oncol. 2013 Mar 20;3:57. doi: 10.3389/fonc.2013.00057. eCollection 2013. Front Oncol. 2013. PMID: 23519678 Free PMC article.
104 results